Evans JL - Search Results

1

Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators.

Lum RT, Cheng M, Cristobal CP, Goldfine ID, Evans JL, Keck JG, Macsata RW, Manchem VP, Matsumoto Y, Park SJ, Rao SS, Robinson L, Shi S, Spevak WR, Schow SR. Lum RT, et al. Among authors: evans jl. J Med Chem. 2008 Oct 9;51(19):6173-87. doi: 10.1021/jm800600v. Epub 2008 Sep 13. J Med Chem. 2008. PMID: 18788731

2

Regulation of insulin receptor function by a small molecule insulin receptor activator.

Pender C, Goldfine ID, Manchem VP, Evans JL, Spevak WR, Shi S, Rao S, Bajjalieh S, Maddux BA, Youngren JF. Pender C, et al. Among authors: evans jl. J Biol Chem. 2002 Nov 15;277(46):43565-71. doi: 10.1074/jbc.M202426200. Epub 2002 Sep 3. J Biol Chem. 2002. PMID: 12213804 Free article.

3

Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators.

Li M, Youngren JF, Dunaif A, Goldfine ID, Maddux BA, Zhang BB, Evans JL. Li M, et al. Among authors: evans jl. J Clin Endocrinol Metab. 2002 Sep;87(9):4088-93. doi: 10.1210/jc.2002-020363. J Clin Endocrinol Metab. 2002. PMID: 12213853

4

Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes.

Evans JL, Goldfine ID. Evans JL, et al. Diabetes Technol Ther. 2000 Autumn;2(3):401-13. doi: 10.1089/15209150050194279. Diabetes Technol Ther. 2000. PMID: 11467343 Review.

5

Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.

Evans JL, Lin JJ, Goldfine ID. Evans JL, et al. Curr Diabetes Rev. 2005 Aug;1(3):299-307. doi: 10.2174/157339905774574365. Curr Diabetes Rev. 2005. PMID: 18220606 Review.

6

Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid.

Evans JL, Heymann CJ, Goldfine ID, Gavin LA. Evans JL, et al. Endocr Pract. 2002 Jan-Feb;8(1):29-35. doi: 10.4158/EP.8.1.29. Endocr Pract. 2002. PMID: 11951812 Clinical Trial.

7

A New Road for Treating the Vascular Complications of Diabetes: So Let's Step on the Gas.

Evans JL, Goldfine ID. Evans JL, et al. Diabetes. 2016 Feb;65(2):346-8. doi: 10.2337/dbi15-0029. Diabetes. 2016. PMID: 26798120 No abstract available.

8

Aging and insulin resistance: just say iNOS.

Evans JL, Goldfine ID. Evans JL, et al. Diabetes. 2013 Feb;62(2):346-8. doi: 10.2337/db12-1239. Diabetes. 2013. PMID: 23349542 Free PMC article. No abstract available.

9

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Evans JL, et al. Diabetes. 2003 Jan;52(1):1-8. doi: 10.2337/diabetes.52.1.1. Diabetes. 2003. PMID: 12502486 Review.

10

The molecular basis for oxidative stress-induced insulin resistance.

Evans JL, Maddux BA, Goldfine ID. Evans JL, et al. Antioxid Redox Signal. 2005 Jul-Aug;7(7-8):1040-52. doi: 10.1089/ars.2005.7.1040. Antioxid Redox Signal. 2005. PMID: 15998259 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters